GlassScriptPhysician profile
Ronald Allen Rubenstein
NPI 1124046610
$3,685.56
in general payments reported to CMS, 2019-2025
43 companies · $631 in 2025
The $631 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $365 · 2021: $622 · 2022: $765 · 2023: $671 · 2024: $430 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,598 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,598.29 |
| Education | $133.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $682.61 | 2019-2024 | Myrbetriq, Xtandi, Veozah |
| Sumitomo Pharma America, INC. | $270.08 | 2023-2025 | Gemtesa, Orgovyx |
| Blue Earth Diagnostics | $227.17 | 2019-2023 | |
| Janssen Biotech, INC. | $218.55 | 2020-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $188.28 | 2021-2024 | Prolaris |
| Calyxo, INC. | $147.29 | 2025 | Cvac Aspiration System |
| Abbvie INC. | $125.12 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.64 | 2021-2023 | |
| Endo Pharmaceuticals INC. | $118.56 | 2019-2023 | Xiaflex |
| Urogen Pharma, INC. | $109.35 | 2022-2025 | Jelmyto |
| Dornier Medtech America, INC | $104.94 | 2023 | Dornier Medtech |
| Olympus America INC. | $103.48 | 2022-2025 | Itind System |
| Endo USA, INC. | $103.13 | 2025 | Xiaflex |
| Coloplast Corp | $90.87 | 2020-2023 | Speedicath |
| Boston Scientific Corporation | $83.76 | 2019 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Rubenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.